New Ways to Skin a Cat or Still a Cat Chasing Its Tail? Bayesian Vancomycin Monitoring in the ICU

Alexander H. Flannery; Katherine B. Landmesser; Ryan P. Mynatt

doi:10.1097/CCM.0000000000005121

New Ways to Skin a Cat or Still a Cat Chasing Its Tail? Bayesian Vancomycin Monitoring in the ICU

Alexander H. Flannery, Katherine B. Landmesser, Ryan P. Mynatt

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	1844-1847
Number of pages	4
Journal	Critical Care Medicine
Volume	49
Issue number	10
DOIs	https://doi.org/10.1097/CCM.0000000000005121
State	Published - Oct 1 2021

Bibliographical note

Funding Information:
The authors report receiving grant support from the American College of Clinical Pharmacy Foundation to study Bayesian vancomycin monitoring. Dr. Flannery’s institution received funding from the American College of Clinical Pharmacy Foundation. Dr. Landmesser received funding from the American College of Clinical Pharmacy Foundation. Dr. Mynatt has disclosed that he does not have any potential conflicts of interest.

Funding Information:
The authors report receiving grant support from the American College of Clinical Pharmacy Foundation to study Bayesian vancomycin monitoring. Dr. Flannery’s institution received funding from the American College of Clinical Pharmacy Foundation. Dr. Landmesser received funding from the American College of Clinical Pharmacy Foundation. Dr. Mynatt has disclosed that he does not have any potential conflicts of interest.

Keywords

Bayesian
critical care
pharmacokinetics
therapeutic drug monitoring
vancomycin

ASJC Scopus subject areas

Critical Care and Intensive Care Medicine

Access to Document

10.1097/CCM.0000000000005121

Cite this

@article{1db446b178e54c2bb9247c15675562e5,

title = "New Ways to Skin a Cat or Still a Cat Chasing Its Tail? Bayesian Vancomycin Monitoring in the ICU",

keywords = "Bayesian, critical care, pharmacokinetics, therapeutic drug monitoring, vancomycin",

author = "Flannery, {Alexander H.} and Landmesser, {Katherine B.} and Mynatt, {Ryan P.}",

note = "Funding Information: The authors report receiving grant support from the American College of Clinical Pharmacy Foundation to study Bayesian vancomycin monitoring. Dr. Flannery{\textquoteright}s institution received funding from the American College of Clinical Pharmacy Foundation. Dr. Landmesser received funding from the American College of Clinical Pharmacy Foundation. Dr. Mynatt has disclosed that he does not have any potential conflicts of interest. Funding Information: The authors report receiving grant support from the American College of Clinical Pharmacy Foundation to study Bayesian vancomycin monitoring. Dr. Flannery{\textquoteright}s institution received funding from the American College of Clinical Pharmacy Foundation. Dr. Landmesser received funding from the American College of Clinical Pharmacy Foundation. Dr. Mynatt has disclosed that he does not have any potential conflicts of interest.",

year = "2021",

month = oct,

day = "1",

doi = "10.1097/CCM.0000000000005121",

language = "English",

volume = "49",

pages = "1844--1847",

number = "10",

}

TY - JOUR

T1 - New Ways to Skin a Cat or Still a Cat Chasing Its Tail? Bayesian Vancomycin Monitoring in the ICU

AU - Flannery, Alexander H.

AU - Landmesser, Katherine B.

AU - Mynatt, Ryan P.

N1 - Funding Information: The authors report receiving grant support from the American College of Clinical Pharmacy Foundation to study Bayesian vancomycin monitoring. Dr. Flannery’s institution received funding from the American College of Clinical Pharmacy Foundation. Dr. Landmesser received funding from the American College of Clinical Pharmacy Foundation. Dr. Mynatt has disclosed that he does not have any potential conflicts of interest. Funding Information: The authors report receiving grant support from the American College of Clinical Pharmacy Foundation to study Bayesian vancomycin monitoring. Dr. Flannery’s institution received funding from the American College of Clinical Pharmacy Foundation. Dr. Landmesser received funding from the American College of Clinical Pharmacy Foundation. Dr. Mynatt has disclosed that he does not have any potential conflicts of interest.

PY - 2021/10/1

Y1 - 2021/10/1

KW - Bayesian

KW - critical care

KW - pharmacokinetics

KW - therapeutic drug monitoring

KW - vancomycin

UR - http://www.scopus.com/inward/record.url?scp=85115953575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85115953575&partnerID=8YFLogxK

U2 - 10.1097/CCM.0000000000005121

DO - 10.1097/CCM.0000000000005121

M3 - Editorial

C2 - 34529619

AN - SCOPUS:85115953575

VL - 49

SP - 1844

EP - 1847

IS - 10

ER -

New Ways to Skin a Cat or Still a Cat Chasing Its Tail? Bayesian Vancomycin Monitoring in the ICU

Bibliographical note

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this